Donald Kennedy Quotes
So here's the situation confronting the drug firms: The drugs cost more to make, but they can't charge more for them. What do they do? Increasingly, the U.S. market is driving them toward drugs aimed at the diseases of richer, older Americans and away from antimicrobials, vaccines, and the like.
Kennedy, Donald. "Drug Discovery." Science, American Association for the Advancement of Science, 2004.
The “inflated prices” refers to the fact Americans pay more for pharmaceuticals than any other country in the world as the American government allows the companies to charge any amounts while other governments either negotiate or mandate much lower prices.
The major killer diseases such as malaria and sleeping sickness are not contracted by Americans, and America is the only large country in the world where the Governments allow the drug companies to charge such high prices and make such huge profits. So any drug that Americans might pay for is a better potential profit generator than one that would be critical to the lives of millions where the governments to preserve lives would force the prices down or allow other companies to also make the drug. See {628648} for other factors affecting drug company priorities.
Donald Kennedy was an American scientist, public administrator, and academic. He served as Commissioner of the U.S. Food and Drug Administration (1977–1979), President of Stanford University (1980–1992), and Editor-in-Chief of Science (2000–2008). Following this, he was named president emeritus of Stanford University; Bing Professor of Environmental Science and Policy, emeritus; and senior fellow of the Freeman Spogli Institute for International Studies.